Lisata Therapeutics Files Initial Beneficial Ownership Statement for Director Jeffrey S. Farrow
Lisata Therapeutics director Jeffrey S. Farrow filed an initial statement of beneficial ownership for an event dated October 13, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-ge